We are live on ! Find out more
CRL icon

Charles River Laboratories

664 hedge funds and large institutions have $10.8B invested in Charles River Laboratories in 2024 Q2 according to their latest regulatory filings, with 74 funds opening new positions, 266 increasing their positions, 235 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 266 | Existing positions reduced: 235

0.06% less ownership

Funds ownership: 101.79%101.73% (-0.06%)

6% less first-time investments, than exits

New positions opened: 74 | Existing positions closed: 79

2% less funds holding

Funds holding: 676664 (-12)

15% less call options, than puts

Call options by funds: $54.2M | Put options by funds: $63.4M

23% less capital invested

Capital invested by funds: $14.1B → $10.8B (-$3.32B)

47% less funds holding in top 10

Funds holding in top 10: 158 (-7)

Holders
664
Holders Change
-12
Holders Change %
-1.78%
% of All Funds
9.59%
Holding in Top 10
8
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-46.67%
% of All Funds
0.12%
New
74
Increased
266
Reduced
235
Closed
79
Calls
$54.2M
Puts
$63.4M
Net Calls
-$9.19M
Net Calls Change
+$37.2M
Name Holding Trade Value Shares
Change
Change in
Stake
ASRS
226
Arizona State Retirement System
Arizona
$2.91M -$680 -3 -0%
MML Investors Services
227
MML Investors Services
Massachusetts
$2.9M -$160K -707 -5%
MIM
228
MetLife Investment Management
New Jersey
$2.84M +$392K +1,730 +14%
Nomura Asset Management
229
Nomura Asset Management
Japan
$2.83M +$29.9K +132 +1%
MIIM
230
Mesirow Institutional Investment Management
Illinois
$2.83M +$3.1M +13,676 New
WR
231
WD Rutherford
Oregon
$2.82M -$212K -936 -6%
NYLIM
232
New York Life Investment Management
New York
$2.8M +$308K +1,361 +11%
CF
233
Corebridge Financial
Texas
$2.72M +$2.98M +13,159 New
AB
234
Amalgamated Bank
New York
$2.69M +$526K +2,323 +22%
PP
235
PDT Partners
New York
$2.64M
Man Group
236
Man Group
United Kingdom
$2.55M +$2.79M +12,333 New
FHB
237
First Hawaiian Bank
Hawaii
$2.54M -$342K -1,509 -11%
Corient Private Wealth
238
Corient Private Wealth
Florida
$2.54M +$453 +2 +0%
PCA
239
Pallas Capital Advisors
Massachusetts
$2.53M +$147K +647 +6%
TPCW
240
TD Private Client Wealth
New York
$2.53M -$5.44K -24 -0.2%
TC
241
TownSquare Capital
Utah
$2.42M -$63.9K -282 -2%
PNC Financial Services Group
242
PNC Financial Services Group
Pennsylvania
$2.4M -$24K -106 -0.9%
Retirement Systems of Alabama
243
Retirement Systems of Alabama
Alabama
$2.35M +$9.29K +41 +0.4%
Millennium Management
244
Millennium Management
New York
$2.34M -$28.3M -124,737 -92%
COPPSERS
245
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$2.34M +$12.2K +54 +0.5%
Nisa Investment Advisors
246
Nisa Investment Advisors
Missouri
$2.31M +$308K +1,361 +14%
HighTower Advisors
247
HighTower Advisors
Illinois
$2.27M -$230K -1,017 -8%
AAF
248
Andra AP-fonden
Sweden
$2.25M -$68K -300 -3%
QIM
249
Quantitative Investment Management
Virginia
$2.22M +$2.44M +10,758 New
ET
250
Entropy Technologies
New York
$2.18M +$1.62M +7,143 +211%

CRL Hedge Fund Activity: Q2 2024 in Review

664 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2024, worth a combined $10.8B — down 23% from $14.1B a quarter earlier.

Sellers outnumbered buyers: 79 funds closed out of CRL and 74 opened new positions — a net loss of 5 holders — while 235 trimmed existing stakes and 266 added.

The largest buyer was Southpoint Capital Advisors, adding an estimated $102M. The largest seller was T. Rowe Price Associates, cutting an estimated $154M.

  • 664 institutional investors held Charles River Laboratories (CRL) as of Q2 2024, down from 676 in Q1 2024.
  • Funds reported $10.8B of Charles River Laboratories stock for Q2 2024, down 23% quarter-over-quarter.
  • 74 funds opened new Charles River Laboratories positions in Q2 2024 and 79 closed out, a net change of -5 holders.
  • The largest Charles River Laboratories buyer in Q2 2024 was Southpoint Capital Advisors, an estimated $102M added.
  • The largest Charles River Laboratories seller in Q2 2024 was T. Rowe Price Associates, an estimated $154M sold.

Based on aggregated 13F filings for Q2 2024.